Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Sotgiu

Showing results (11-20 of 577) with videos related to

Pageof 58
Sort By:
The European Respiratory Journal|July 2, 2014
Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosisGiovanni Sotgiu, Mark Woodhead
The Lancet. Respiratory Medicine|January 14, 2021
Improving clinical management of COVID-19: the role of prediction modelsLaure Wynants, Giovanni Sotgiu
The Lancet. Public Health|December 19, 2017
Prevention of tuberculosis transmission through medical surveillance systemsGiovanni Sotgiu, Giovanni Battista Migliori
The European Respiratory Journal|July 8, 2020
Social stigma in the time of coronavirus disease 2019Giovanni Sotgiu, Claudia C Dobler
The Lancet. Infectious Diseases|November 26, 2015
Long-term protectiveness of BCGGiovanni Sotgiu, Giovanni Battista Migliori
The Lancet. Infectious Diseases|July 12, 2016
Better data, more tailored tuberculosis therapiesGiovanni Sotgiu, Giovanni Battista Migliori
Lancet (London, England)|March 22, 2014
Measuring the effect of tuberculosis control: a step forwardGiovanni Battista Migliori, Giovanni Sotgiu
Lancet (London, England)|July 26, 2012
Treatment of tuberculosis: have we turned the corner?Giovanni Battista Migliori, Giovanni Sotgiu
Lancet (London, England)|March 22, 2015
New effective antituberculosis regimensGiovanni Sotgiu, Giovanni Battista Migliori
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 13, 2016
TB-related mortality: a re-emerging problem in high-income countries?Giovanni Sotgiu, Giovanni Battista Migliori
Pageof 58

Showing results (11-20 of 577) with videos related to

Sort By:
Pageof 58
The European Respiratory Journal|July 2, 2014
Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosisGiovanni Sotgiu, Mark Woodhead
The Lancet. Respiratory Medicine|January 14, 2021
Improving clinical management of COVID-19: the role of prediction modelsLaure Wynants, Giovanni Sotgiu
The Lancet. Public Health|December 19, 2017
Prevention of tuberculosis transmission through medical surveillance systemsGiovanni Sotgiu, Giovanni Battista Migliori
The European Respiratory Journal|July 8, 2020
Social stigma in the time of coronavirus disease 2019Giovanni Sotgiu, Claudia C Dobler
The Lancet. Infectious Diseases|November 26, 2015
Long-term protectiveness of BCGGiovanni Sotgiu, Giovanni Battista Migliori
The Lancet. Infectious Diseases|July 12, 2016
Better data, more tailored tuberculosis therapiesGiovanni Sotgiu, Giovanni Battista Migliori
Lancet (London, England)|March 22, 2014
Measuring the effect of tuberculosis control: a step forwardGiovanni Battista Migliori, Giovanni Sotgiu
Lancet (London, England)|July 26, 2012
Treatment of tuberculosis: have we turned the corner?Giovanni Battista Migliori, Giovanni Sotgiu
Lancet (London, England)|March 22, 2015
New effective antituberculosis regimensGiovanni Sotgiu, Giovanni Battista Migliori
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 13, 2016
TB-related mortality: a re-emerging problem in high-income countries?Giovanni Sotgiu, Giovanni Battista Migliori
Pageof 58